284sek
-1,6 %
Date:2025-05-13Time:18:00:00Latest report:Q4-2024List:First NorthTicker:CLS B
Market Cap:72 msekEnterprise Value:50 msekNet Sales:18,8 msekEarnings:-47,6 msekEmployees:0ISIN:SE0022049920

Ratios

10-year key figure history for Clinical Laserthermia turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Clinical Laserthermia with index and moving average MA50 and MA200.

Stockprice:2,84
MA50:3,03
MA200:4,20
Price/MA200:-32,5 %
RSI (14):43,6
Price/MA50:-6,4 %

Description

Clinical Laserthermia Systems is a company active in medical technology. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as malignant melanoma, as well as cancer in the lungs, liver, and pancreas. The company was founded in 2006 and is headquartered in Lund.

Medical Equipment